Received Apr 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
late 2nd dose/patient had already received 1 dose in 2022; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 78-year-old female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Shingrix 1 dose in 2022). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: late 2nd dose/patient had already received 1 dose in 2022). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 01-APR-2026 The pharmacist called to informed that a patient had come to the pharmacy to get Shingrix, and when they were checking the records, it looked like the patient had already received 1 dose in 2022, as it was prescribed by their physician, but had not finished the series on time.